Status:

ACTIVE_NOT_RECRUITING

Robot-Assisted Rehabilitation After HIV-Associated Stroke: Botswana

Lead Sponsor:

University of Pennsylvania

Conditions:

HIV/AIDS

Stroke

Eligibility:

All Genders

18-90 years

Phase:

NA

Brief Summary

Today, nearly 37 million people are living with HIV (PLHIV) worldwide and 30 to 40% of them will have neurologic complications leading to disability. Our long-term working hypothesis is that an effect...

Detailed Description

We will test the feasibility of affordable robot therapy in three Aims. In Aim 1, we will optimize for the Botswana context, an affordable technology-based robot system with four exercise stations. We...

Eligibility Criteria

Inclusion

  • diagnosis of Stroke (at least 3 months post incident) with or without HIV, age over 18;
  • medically stable (Able to tolerate therapy and given the determination as able to go through protocol by physician);
  • have neurological function between 5 and 24 as defined by the NIH Stroke Scale (NIHSS);
  • have no less than moderate cognitive function as defined by the International HIV-Dementia Scale
  • Able to give consent.

Exclusion

  • unable to give consent;
  • severely depressed (Becks Depression Inventory-Fast Screener);
  • experiencing excessive pain (Visual Analog Scale (VAS) score greater than 4);
  • have severe spasticity ( than 3) in muscle tone in elbow/shoulder/wrist hip/knee/ankle using the Ashworth Scale;
  • have total paralysis or muscular contractures of upper or lower extremity;
  • have a history of psychiatric disorder or cardiac problems;
  • have a history of prior brain injury including lesions to the cerebella or brain stem;
  • have open lesions on the upper or lower limbs;
  • It is up to the physician to decide if a subject should be excluded due to severe drug and/or alcohol abuse or taking of medication that would impair cognitive ability.

Key Trial Info

Start Date :

October 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 1 2026

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT04488250

Start Date

October 1 2020

End Date

May 1 2026

Last Update

July 3 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Penn Medicine Rittenhouse

Philadelphia, Pennsylvania, United States, 19146

2

University of Botswana

Gaborone, Botswana